Imidazopyridines and imidazopyrazines as LSD1 inhibitors
US10640503B2 · kind B2 · utility
7Cited by
25References
66Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 18, 2018 |
| Grant date | May 5, 2020 |
| Priority date | — |
| Expiry date | Jul 18, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is directed to imidazo[1,5-a]pyridine and imidazo[1,5-a]pyrazine derivatives of Formula I, or a pharmaceutically acceptable salt thereof, which are LSD1 inhibitors useful in the treatment of diseases such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.